# EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings

> **NCT07056036** · NA · COMPLETED · sponsor: **BTL Industries Ltd.** · enrollment: 51 (actual)

## Conditions studied

- Self-Control
- Food Cravings

## Interventions

- **DEVICE:** ActiveTreatment with BTL-699-2
- **DEVICE:** Sham Treatment with BTL-699-2

## Key facts

- **NCT ID:** NCT07056036
- **Lead sponsor:** BTL Industries Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-10-10
- **Final completion:** 2025-10-10
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07056036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07056036, "EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07056036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*